• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新西兰米德兰地区患者报告的结直肠癌诊断间隔时间:一项前瞻性队列研究。

Patient-reported diagnostic intervals to colorectal cancer diagnosis in the Midland region of New Zealand: a prospective cohort study.

机构信息

Medical Research Centre, University of Waikato, Hamilton, New Zealand.

Auckland University of Technology, Auckland, New Zealand.

出版信息

Fam Pract. 2022 Jul 19;39(4):639-647. doi: 10.1093/fampra/cmab155.

DOI:10.1093/fampra/cmab155
PMID:34871389
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9295611/
Abstract

BACKGROUND AND OBJECTIVES

New Zealand (NZ) has high rates of colorectal cancer (CRC) but low rates of early detection. The majority of CRC is diagnosed through general practice, where lengthy diagnostic intervals are common. We investigated factors contributing to diagnostic delay in a cohort of patients newly diagnosed with CRC.

METHODS

Patients were recruited from the Midland region and interviewed about their diagnostic experience using a questionnaire based on a modified Model of Pathways to Treatment framework and SYMPTOM questionnaire. Descriptive statistics were used to describe the population characteristics. Chi-square analysis and logistic regression were used to analyse factors influencing diagnostic intervals.

RESULTS

Data from 176 patients were analysed, of which 65 (36.9%) experienced a general practitioner (GP) diagnostic interval of >120 days and 96 (54.5%) experienced a total diagnostic interval (TDI) > 120 days. Patients reporting rectal bleeding were less likely to experience a long TDI (odds ratio [OR] 0.34, 95% confidence interval [CI]: 0.14-0.78) and appraisal/help-seeking interval (OR, 0.19, 95% CI: 0.06-0.59). Patients <60 were more likely to report a longer appraisal/help-seeking interval (OR, 3.32, 95% CI: 1.17-9.46). Female (OR, 2.19, 95% CI: 1.08-4.44) and Māori patients (OR, 3.18, 95% CI: 1.04-9.78) were more likely to experience a long GP diagnostic interval.

CONCLUSION

NZ patients with CRC can experience long diagnostic intervals, attributed to patient and health system factors. Young patients, Māori, females, and patients experiencing change of bowel habit may be at particular risk. We need to increase symptom awareness of CRC for patients and GPs. Concentrated efforts are needed to ensure equity for Māori in access to screening, diagnostics, and treatment.

摘要

背景和目的

新西兰(NZ)结直肠癌(CRC)发病率较高,但早期发现率较低。大多数 CRC 是通过全科医生诊断出来的,而在那里,诊断间隔通常很长。我们调查了新诊断为 CRC 的患者队列中导致诊断延迟的因素。

方法

从米德兰地区招募患者,并使用基于改良治疗途径模型和症状问卷的问卷对其诊断经验进行访谈。使用描述性统计来描述人群特征。使用卡方分析和逻辑回归分析影响诊断间隔的因素。

结果

对 176 名患者的数据进行了分析,其中 65 名(36.9%)的全科医生(GP)诊断间隔超过 120 天,96 名(54.5%)的总诊断间隔(TDI)超过 120 天。报告直肠出血的患者不太可能经历较长的 TDI(优势比[OR]0.34,95%置信区间[CI]:0.14-0.78)和评估/寻求帮助间隔(OR,0.19,95%CI:0.06-0.59)。<60 岁的患者更有可能报告较长的评估/寻求帮助间隔(OR,3.32,95%CI:1.17-9.46)。女性(OR,2.19,95%CI:1.08-4.44)和毛利人患者(OR,3.18,95%CI:1.04-9.78)更有可能经历较长的 GP 诊断间隔。

结论

新西兰 CRC 患者可能会经历较长的诊断间隔,这归因于患者和卫生系统因素。年轻患者、毛利人、女性和经历排便习惯改变的患者可能面临特别高的风险。我们需要提高患者和全科医生对 CRC 症状的认识。需要集中精力确保毛利人在获得筛查、诊断和治疗方面的公平性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e82/9295611/a66ee29ec278/cmab155_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e82/9295611/a66ee29ec278/cmab155_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e82/9295611/a66ee29ec278/cmab155_fig1.jpg

相似文献

1
Patient-reported diagnostic intervals to colorectal cancer diagnosis in the Midland region of New Zealand: a prospective cohort study.新西兰米德兰地区患者报告的结直肠癌诊断间隔时间:一项前瞻性队列研究。
Fam Pract. 2022 Jul 19;39(4):639-647. doi: 10.1093/fampra/cmab155.
2
How do colorectal cancer patients rate their GP: a mixed methods study.结直肠癌患者如何评价他们的全科医生:一项混合方法研究。
BMC Fam Pract. 2021 Apr 8;22(1):67. doi: 10.1186/s12875-021-01427-7.
3
Barriers and facilitators to colorectal cancer diagnosis in New Zealand: a qualitative study.新西兰结直肠癌诊断的障碍和促进因素:一项定性研究。
BMC Fam Pract. 2020 Oct 1;21(1):206. doi: 10.1186/s12875-020-01276-w.
4
Outcomes from colonoscopy following referral from New Zealand general practice: a retrospective analysis.新西兰普通实践转诊后的结肠镜检查结果:一项回顾性分析。
BMC Gastroenterol. 2021 Dec 15;21(1):471. doi: 10.1186/s12876-021-02042-7.
5
Why does New Zealand have such poor outcomes from colorectal cancer?: the importance of the pre-diagnostic period.为何新西兰的结直肠癌治疗效果如此之差?:诊断前时期的重要性。
J Prim Health Care. 2021 Mar;13(1):15-26. doi: 10.1071/HC20049.
6
New Zealanders' experiences and pathways to a diagnosis of bowel cancer: a cross-sectional descriptive study of a younger cohort.新西兰人患肠癌的诊断经历及途径:一项针对较年轻队列的横断面描述性研究。
N Z Med J. 2018 Oct 5;131(1483):30-39.
7
Greenlandic patients with colorectal cancer: symptomatology, primary investigations and differences in diagnostic intervals between Nuuk and the rest of the country.格陵兰结直肠癌患者:症状学、初步检查以及努克与该国其他地区诊断间隔的差异。
Int J Circumpolar Health. 2017;76(1):1344086. doi: 10.1080/22423982.2017.1344086.
8
General practitioner characteristics and delay in cancer diagnosis. a population-based cohort study.全科医生的特征与癌症诊断延迟:一项基于人群的队列研究。
BMC Fam Pract. 2011 Sep 26;12:100. doi: 10.1186/1471-2296-12-100.
9
A symptom-based model to predict colorectal cancer in low-resource countries: Results from a prospective study of patients at high risk for colorectal cancer.基于症状的模型预测资源匮乏国家的结直肠癌:一项对结直肠癌高危患者前瞻性研究的结果。
Cancer. 2018 Jul 1;124(13):2766-2773. doi: 10.1002/cncr.31399. Epub 2018 Apr 12.
10
People with early-onset colorectal cancer describe primary care barriers to timely diagnosis: a mixed-methods study of web-based patient reports in the United Kingdom, Australia and New Zealand.早发性结直肠癌患者描述了初级保健诊断及时性的障碍:英国、澳大利亚和新西兰基于网络的患者报告的混合方法研究。
BMC Prim Care. 2023 Jan 14;24(1):12. doi: 10.1186/s12875-023-01967-0.

本文引用的文献

1
Outcomes from colonoscopy following referral from New Zealand general practice: a retrospective analysis.新西兰普通实践转诊后的结肠镜检查结果:一项回顾性分析。
BMC Gastroenterol. 2021 Dec 15;21(1):471. doi: 10.1186/s12876-021-02042-7.
2
Why does New Zealand have such poor outcomes from colorectal cancer?: the importance of the pre-diagnostic period.为何新西兰的结直肠癌治疗效果如此之差?:诊断前时期的重要性。
J Prim Health Care. 2021 Mar;13(1):15-26. doi: 10.1071/HC20049.
3
Barriers and facilitators to colorectal cancer diagnosis in New Zealand: a qualitative study.
新西兰结直肠癌诊断的障碍和促进因素:一项定性研究。
BMC Fam Pract. 2020 Oct 1;21(1):206. doi: 10.1186/s12875-020-01276-w.
4
Evidence of inequitable use of chemotherapy in New Zealand colorectal cancer patients.新西兰结直肠癌患者化疗使用不平等的证据。
N Z Med J. 2020 Aug 21;133(1520):15-26.
5
Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study.1995-2014 年七个高收入国家癌症存活率、死亡率和发病率的进展(ICBP SURVMARK-2):一项基于人群的研究。
Lancet Oncol. 2019 Nov;20(11):1493-1505. doi: 10.1016/S1470-2045(19)30456-5. Epub 2019 Sep 11.
6
The factors that lead to a delay between general practitioner referral of symptomatic patients and specialist diagnosis of colorectal cancer: an audit in the Bay of Plenty District Health Board.导致有症状患者从全科医生转诊至结直肠癌专科诊断之间出现延迟的因素:丰盛湾地区卫生局的一项审计
N Z Med J. 2019 Mar 8;132(1491):27-37.
7
New Zealanders' experiences and pathways to a diagnosis of bowel cancer: a cross-sectional descriptive study of a younger cohort.新西兰人患肠癌的诊断经历及途径:一项针对较年轻队列的横断面描述性研究。
N Z Med J. 2018 Oct 5;131(1483):30-39.
8
The New Zealand PIPER Project: colorectal cancer survival according to rurality, ethnicity and socioeconomic deprivation-results from a retrospective cohort study.新西兰派珀项目:根据农村地区、种族和社会经济剥夺状况分析结直肠癌生存率——一项回顾性队列研究的结果
N Z Med J. 2018 Jun 8;131(1476):24-39.
9
From symptom discovery to treatment - women's pathways to breast cancer care: a cross-sectional study.从症状发现到治疗——女性乳腺癌护理途径:一项横断面研究。
BMC Cancer. 2018 Mar 21;18(1):312. doi: 10.1186/s12885-018-4219-7.
10
Barriers to contacting general practice with alarm symptoms of colorectal cancer: a population-based study.结直肠癌警报症状患者联系全科医疗的障碍:一项基于人群的研究。
Fam Pract. 2018 Jul 23;35(4):399-405. doi: 10.1093/fampra/cmx117.